A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy-Reference-Cited by-同舟云学术

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy

Published:2000-03 Issue:2 Volume:9 Page:80-87
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Betts T,Waegemans T,Crawford P

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference13 articles.

1. The new generation of antiepileptic drugs: advantages and disadvantages;Perucca;British Journal of Clinical Pharmacology,1996

2. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures;Mattson;New England Journal of Medicine,1985

3. New drugs for the treatment of epilepsy;Löscher;Current Opinion Investigating Drugs,1993

4. Early tolerance to antiepileptic drug side effects: a controlled trial of 247 patients;Mattson,1986

5. Anticonvulsants;Schmidt,1992

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis;Epilepsia Open;2024-06-18

2. Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of primary generalized tonic–clonic seizures;Epilepsia;2024-06-12

3. Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetam;Epilepsy Research;2024-05

4. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy;BMC Cancer;2023-09-11

5. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis;CNS Drugs;2023-08-17